Theriva Biologics Inc (TOVX)
1.28
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
1.29
+0.01
(+0.78%)
After-Hours: 20:00
Theriva Biologics Cash from Operations (Quarterly): -3.913M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.913M |
| June 30, 2024 | -3.452M |
| March 31, 2024 | -4.881M |
| December 31, 2023 | -6.541M |
| September 30, 2023 | -2.953M |
| June 30, 2023 | -3.892M |
| March 31, 2023 | -5.61M |
| December 31, 2022 | -5.368M |
| September 30, 2022 | -4.456M |
| June 30, 2022 | -4.356M |
| March 31, 2022 | -4.902M |
| December 31, 2021 | -4.81M |
| September 30, 2021 | -2.156M |
| June 30, 2021 | -2.596M |
| March 31, 2021 | -3.328M |
| December 31, 2020 | -3.132M |
| September 30, 2020 | -2.05M |
| June 30, 2020 | -2.026M |
| March 31, 2020 | -4.96M |
| December 31, 2019 | -3.605M |
| September 30, 2019 | -3.062M |
| June 30, 2019 | -2.982M |
| March 31, 2019 | -4.224M |
| December 31, 2018 | -3.29M |
| September 30, 2018 | -3.602M |
| Date | Value |
|---|---|
| June 30, 2018 | -4.308M |
| March 31, 2018 | -6.079M |
| December 31, 2017 | -3.932M |
| September 30, 2017 | -4.524M |
| June 30, 2017 | -5.74M |
| March 31, 2017 | -6.008M |
| December 31, 2016 | -10.38M |
| September 30, 2016 | -5.983M |
| June 30, 2016 | -5.86M |
| March 31, 2016 | -5.674M |
| December 31, 2015 | -10.97M |
| September 30, 2015 | -15.21M |
| June 30, 2015 | -7.25M |
| March 31, 2015 | -5.458M |
| December 31, 2014 | -4.779M |
| September 30, 2014 | -4.535M |
| June 30, 2014 | -3.295M |
| March 31, 2014 | -3.47M |
| December 31, 2013 | -2.704M |
| September 30, 2013 | -1.72M |
| June 30, 2013 | -1.633M |
| March 31, 2013 | -1.662M |
| December 31, 2012 | -4.773M |
| September 30, 2012 | -1.442M |
| June 30, 2012 | -1.286M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.541M
Minimum
Dec 2023
-2.026M
Maximum
Jun 2020
-3.949M
Average
-3.902M
Median
Cash from Operations (Quarterly) Benchmarks
| Merck & Co Inc | 9.291B |
| Pro-Dex Inc | 1.887M |
| BioCardia Inc | -2.611M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 3.716M |
| Free Cash Flow | -18.84M |
| Free Cash Flow Per Share (Quarterly) | -3.449 |
| Free Cash Flow Yield | -1.80K% |